Logo

Collaborative Medicinal Development, LLC Reports that Lead Dru...

MILL VALLEY, California, June 10, 2019 /PRNewswire-AsiaNet/ -- Collaborative Medicinal Development LLC ("CMD"), a privately-held biopharmaceutical company developing innovative therapies for neurodegenerative diseases, will report promising results from its phase 1, non-placebo controlled, dose-finding study ...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Asian Spectator by NewsServices.com - office@NewsServices.com - 1300 660 660